733-20183-92104
3 vaccinations
8 coded responses
34 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 787 / TX
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-29
Survey response — day 21, dose 2MedDRA: Diarrhoea — Feeling: FairFree text: Diarrhea 1/28/21 after a 7 days of augmentin for dental work.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Anosmia, Hypogeusia, Hyposmia, SARS-CoV-2 test negative, Taste disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Decreased taste and smell to half strength but negative covid pcr x 2, 48 hours apartMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-12
- 2021-02-19
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: Inflammation — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Inflammation of rotator cuff tendons of left armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-14
-
2021-06-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-07-09
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-10-01
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: These are all chronic, due to MS, migraines, and delayed treatment for a shoulder injury due to the pandemic.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: As per previous reports, these are chronicMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — day 7, dose 3Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-13
- 2021-10-20
-
2021-10-27
Survey response — day 28, dose 3MedDRA: Diarrhoea — Feeling: GoodFree text: Loose stools for 5 daysMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
- 2021-11-10
- 2021-12-29
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Fungal infection, Oral candidiasis, Unevaluable event, Vulvovaginitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Vulvovaginitis x 4 in past year with no history. Presumed to be yeast infections and treated with oral fluconazole. Oral thrush vs geographic tongue x 2 in the past 6 months (concurrent with vulvovaginitis) with no history.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-05
-
2022-10-02
Survey response — 12 months, dose 3MedDRA: Ageusia, Cough, Glossitis, Laryngitis, Menopause, Oropharyngeal pain, Rhinorrhoea, Sneezing, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Current URI- sore throat, runny nose, cough, sneezing, laryngitis Perimenopause Glossitis with loss of taste budsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 3 — day 21, dose 2
Symptoms: Diarrhea 1/28/21 after a 7 days of augmentin for dental work.
Release 3 — day 28, dose 2
Symptoms: Decreased taste and smell to half strength but negative covid pcr x 2, 48 hours apart
Release 7 — 3 months, dose 2
Symptoms: Inflammation of rotator cuff tendons of left arm
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): These are all chronic, due to MS, migraines, and delayed treatment for a shoulder injury due to the pandemic.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): As per previous reports, these are chronic
Release 10 — day 28, dose 3
Symptoms: Loose stools for 5 days
Release 11 — 6 months, dose 3
Symptoms: Vulvovaginitis x 4 in past year with no history. Presumed to be yeast infections and treated with oral fluconazole. Oral thrush vs geographic tongue x 2 in the past 6 months (concurrent with vulvovaginitis) with no history.
Release 12 — 12 months, dose 3
Symptoms: Current URI- sore throat, runny nose, cough, sneezing, laryngitis Perimenopause Glossitis with loss of taste buds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | ✓ | ✓ | ○ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fungal infection | · | · | ✓ |
| SD | Glossitis | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Menopause | · | · | ✓ |
| SD | Oral candidiasis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Taste disorder | ✓ | ✓ | ○ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Vulvovaginitis | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release